Trump Admin Busts Haitian National in $58M Drug Clinic Fraud
A Haitian national was sentenced for orchestrating a $58 million fraud scheme exploiting a federal drug discount program by running fake HIV clinics that discarded medications while billing taxpayers.
Jean Jethro Alexandre was sentenced this spring to prison time and ordered to pay $14.3 million in restitution after federal prosecutors in Florida charged him with running two clinics as fraudulent prescription mills, as Breitbart News reports. The case formed part of what authorities described as the largest health care fraud takedown in American history.
Alexandre’s clinics ostensibly provided treatment for HIV and other sexually transmitted diseases. In reality, prosecutors say, they existed solely to exploit the 340B Drug Discount Program, which offers deep discounts on HIV medications to qualifying health facilities.
How the Fraud Worked
Federal prosecutors laid out in detail how Alexandre allegedly manipulated the 340B system. His operations paid kickbacks to recruiters and so-called patients who were willing to request prescriptions. The clinics then falsified dispensing records while disposing of the medications entirely, since actually providing life-saving drugs to patients was never part of the scheme.
The drugs, intended for low-income HIV patients and purchased at taxpayer-subsidized discounts, were thrown away while the fake clinics submitted bills as though the medicine had been properly dispensed. Prosecutors estimated the fraud totaled roughly $58 million in false claims.
A Program Built for Abuse
The 340B Drug Discount Program was designed with the stated goal of allowing clinics to purchase medicines cheaply and extend those savings to lower-income patients. But the program has become a magnet for fraud and abuse, operating with minimal verification of where subsidized drugs actually end up.
The program’s growth has been explosive. Discounted purchases under 340B surged from approximately $5 billion in 2010 to more than $66 billion in 2023, distributed across thousands of covered entities and contract pharmacies. High-cost specialty drugs and antiretrovirals, the focus of Alexandre’s scheme, are particularly lucrative targets for fraudsters.
A Model That Likely Exists Elsewhere
According to Americans for Limited Government executive director Robert Romano, there is good reason to believe Alexandre’s scheme is not an isolated incident. When a subsidy of this magnitude operates with light oversight, it practically invites criminal exploitation.
The Department of Health and Human Services has acknowledged the risks. A pilot program was launched to reform the rebate system and ensure payment integrity, but litigation has delayed full implementation.
Call for Expanded Enforcement
The case represents exactly the type of fraud the White House Fraud Task Force, chaired by Vice President JD Vance and FTC Chairman Andrew Ferguson, was created to pursue. The task force has demonstrated its ability to mobilize resources and attention rapidly across agencies.
Rather than treating the Florida clinics as an isolated case, the task force should recognize Alexandre’s operation as a replicable model that almost certainly exists in other jurisdictions. His scheme was neither exotic nor difficult to execute—it was the obvious play when the 340B Program offers massive handouts with few questions asked.
Justice has been served in this single instance, but without systemic reform and aggressive enforcement, the 340B program will continue to serve as an open invitation to criminals willing to steal from American taxpayers while denying vital medications to vulnerable patients.
With information from Breitbart News
